3rd Epigenetics Conference: from Mechanisms to Disease #3EPI22
Cancun, Mexico
Registration
General Information
The DNA of eukaryotic cells is organized into chromatin. Chromatin is the template of life. It is the vector of genetic information and it is at the core of fundamental processes such as gene regulation, stem cell fate determination and cancer. The study of chromatin structure and function and the study of mechanisms of disease and their diagnostic and therapeutic approaches are mostly covered by separate meetings. However, the boundaries among these various disciplines are disappearing and now, the meeting on “Epigenetics: from mechanisms to disease” will bring together scientists studying chromatin architecture, epigenetics, stem cell biology cancer and other diseases. The talks will cover a broad range of topics, including chromosome organisation, long-range interactions, chromatin assembly, stem cell regulation/differentiation, RNA-based mechanisms, transcription regulation, DNA methylation and hydroxymethylation, as well as the use of genome engineering technologies, single-cell approaches and cutting edge epigenomics and imaging approaches.
Speakers have been selected to broadly reflect lessons learned from a variety of model organisms and experimental approaches. Young scientists will be able to present their work through a large number of short talks selected from submitted abstracts as well as through poster presentation. The program has also allocated ample time for exchanging ideas and discussing novel hypotheses at the end of each session, as well as time for informal interactions and networking.
Contact: admin@fusion-conferences.com
Speakers:
Karen Adelman (Harvard Medical School)
CONTROLLING TRANSCRIPTION AT CODING AND NON-CODING LOCI
Genevieve Almouzni (Research center at the Institut Curie)
HISTONE VARIANTS AND CHAPERONES IN CANCER
Salvador Aznar-Benitah (IRB Barcelona)
DIETARY METABOLITES ESTABLISH AN EPIGENETIC MEMORY IN METASTASIS-INITIATING CELLS, MECHANISMS AND POTENTIAL THERAPIES.
Shelley Berger (University of Pennsylvania)
EPIGENETIC PATHWAYS AS TARGETS IN HUMAN DISEASE
Anne Brunet (Stanford University)
EPIGENETIC REGULATION OF AGING STEM CELLS
Irene Chiolo (University of Southern California)
Elena Ezhkova (Icahn School of Medicine at Mount Sinai)
Francois Fuks (University of Brussels)
ROLE OF RNA MODIFICATIONS IN CANCER
Cigall Kadoch (Dana-Farber Cancer Institute/ Harvard Medical School)
Tony Kouzarides (University of Cambridge)
RNA MODIFICATIONS: THEIR FUNCTION AND ROLE IN CANCER
Mounia Lagha (CNRS)
TRANSCRIPTION DYNAMICS AND MEMORY DURING ZYGOTIC GENOME ACTIVATION
Nicola Iovino (Max Planck Institute of Immunology & Epigenetics)
Diego Pasini (European Institute of Oncology)
Rab Prinjha (GlaxoSmithKline)
CHALLENGES AND OPPORTUNITIES IN PROGRESSING EPIGENETIC THERAPEUTICS
Danny Reinberg (HHMI/NYU Langone School of Medicine)
POLYCOMB, INHERITANCE AND DISEASE
Robert Schneider (Institute of Functional Epigenetics, HMGU)
Ramin Shiekhattar (University of Miami)
Ali Shilatifard (Northwestern University)
PRINCIPLES OF EPIGENETICS AND CHROMATIN IN DEVELOPMENT AND HUMAN DISEASE
Jane Skok (NYU Langone Health)
THE IMPACT OF CANCER ASSOCIATED CTCF MUTATIONS ON CHROMATIN STRUCTURE AND GENE REGULATION
Maria-Elena Torres-Padilla (Helmholtz Zentrum München)
EPIGENETIC MECHANISMS OF CELLULAR PLASTICITY AND REPROGRAMMING TO TOTIPOTENCY
